Super‐stable homogeneous embolic agents advance the treatment of hepatocellular carcinoma

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (81925019, U1705281, U22A20333, 82202330)
  • Fundamental Research Funds for the Central Universities (2020Y4003, 20720200019)

This publication has 12 references indexed in Scilit: